GRI · GRI Bio, Inc.
$1.90
-0.02 (-1.04%)
At close · Sep 1
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$4.26M
Shares
2.19M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-09-05 00:00 UTC | GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026 | Event |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-03-02 | H.C. Wainwright KOL Event | Event |
| 2026-02-11 | Corporate Connect Webinar Series hosted by Webull Financial | Event |
| 2025-05-18 | 2025 ATS International Conference | Conference |
Source: https://gribio.com/investors/
Key facts
CIK
1824293
CUSIP
3622AW502
13F (30d)
12 filings
12 filers
Visit website
Investor relations